UMIN-CTR Clinical Trial

Recruitment status Preinitiation
Unique ID issued by UMIN UMIN000046822
Receipt No. R000053418
Scientific Title Effects of Peripheral neuromodulotor prior to rehabilitation intervention on motor recovery after cervical spinal cord injury and the neural basis
Date of disclosure of the study information 2022/02/03
Last modified on 2022/02/03 (Ver. 1)

* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments


Basic information
Public title Effects of Peripheral neuromodulotor prior to rehabilitation intervention on motor recovery after cervical spinal cord injury and the neural basis
Acronym Neurorehabilitation of cervical spinal cord injury
Scientific Title Effects of Peripheral neuromodulotor prior to rehabilitation intervention on motor recovery after cervical spinal cord injury and the neural basis
Scientific Title:Acronym Neurorehabilitation of upper motor recovery after cervical spinal cord injury
Region
Japan

Condition
Condition cervical spinal cord injury
Classification by specialty
Rehabilitation medicine
Classification by malignancy Others
Genomic information NO

Objectives
Narrative objectives1 To investigate whether neuromodulators at the periphery prior to physical intervention would b e effective for improving upper extremity paresi s after cervical spinal cord injury and to explore the underlying mechanism of motor recovery us ing near infrared spectroscopy
Basic objectives2 Efficacy
Basic objectives -Others
Trial characteristics_1
Trial characteristics_2
Developmental phase

Assessment
Primary outcomes ASIA motor scale
Key secondary outcomes

Base
Study type Interventional

Study design
Basic design Parallel
Randomization Randomized
Randomization unit Individual
Blinding Single blind -investigator(s) and assessor(s) are blinded
Control Placebo
Stratification YES
Dynamic allocation YES
Institution consideration Institution is considered as adjustment factor in dynamic allocation.
Blocking YES
Concealment Central registration

Intervention
No. of arms 2
Purpose of intervention Treatment
Type of intervention
Device,equipment
Interventions/Control_1 neuromodulators prior to physical therapy
Interventions/Control_2 physical therapy only
Interventions/Control_3
Interventions/Control_4
Interventions/Control_5
Interventions/Control_6
Interventions/Control_7
Interventions/Control_8
Interventions/Control_9
Interventions/Control_10

Eligibility
Age-lower limit
20 years-old <=
Age-upper limit
80 years-old >=
Gender Male and Female
Key inclusion criteria 1)age ranging 20 to 80
2)within 1 month of injury onset
3)severe key muscles disabilities of upper extremity correspond to MMT 1-2/5
4)conscious alert
5)sound cognition
6)stable physical state
7)normal blood pressure
8)no fracture of target extremities
Key exclusion criteria unconsciousness
dementia
psychiatric disorder or mental disorders
epilepsy
unstable physical state
metal implantation including Pace maker
severe arhythmia or sever CHF
myogenic diseases
Target sample size 40

Research contact person
Name of lead principal investigator
1st name Shigeru
Middle name
Last name Obayashi
Organization Saitama medical center Saitama medical university
Division name department of rehabilitation medicine
Zip code 350-8550
Address 1981 kamoda kawagoe-city, saitama, Japan
TEL 049-228-3529
Email ohbayash@saitama-med.ac.jp

Public contact
Name of contact person
1st name Shigeru
Middle name
Last name Obayash
Organization Saitama medical center Saitama medical university
Division name department of rehabilitation medicine
Zip code 350-8550
Address 1981 kamoda kawagoe-city, saitama, Japan
TEL 049-228-3529
Homepage URL
Email ohbayash@saitama-med.ac.jp

Sponsor
Institute saitama medical university
Institute
Department

Funding Source
Organization Japan Society for the Promotion of Science
Organization
Division
Category of Funding Organization Japanese Governmental office
Nationality of Funding Organization

Other related organizations
Co-sponsor
Name of secondary funder(s)

IRB Contact (For public release)
Organization Saitama medical center Saitama medical university
Address 1981 kamoda kawagoe-city, saitama, Japan
Tel 049-228-3529
Email ohbayash@saitama-med.ac.jp

Secondary IDs
Secondary IDs NO
Study ID_1
Org. issuing International ID_1
Study ID_2
Org. issuing International ID_2
IND to MHLW

Institutions
Institutions 埼玉医科大学総合医療センター(埼玉県)

Other administrative information
Date of disclosure of the study information
2022 Year 02 Month 03 Day

Related information
URL releasing protocol
Publication of results Unpublished

Result
URL related to results and publications
Number of participants that the trial has enrolled
Results
Results date posted
Results Delayed
Results Delay Reason
Date of the first journal publication of results
Baseline Characteristics
Participant flow
Adverse events
Outcome measures
Plan to share IPD
IPD sharing Plan description

Progress
Recruitment status Preinitiation
Date of protocol fixation
2022 Year 02 Month 03 Day
Date of IRB
Anticipated trial start date
2022 Year 02 Month 03 Day
Last follow-up date
2025 Year 03 Month 31 Day
Date of closure to data entry
Date trial data considered complete
Date analysis concluded

Other
Other related information

Management information
Registered date
2022 Year 02 Month 03 Day
Last modified on
2022 Year 02 Month 03 Day


Link to view the page
URL(English) https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000053418